Copyright © 2024 All rights reserved | Ameco Research
Press Release

Transcatheter Devices Market to Reach USD 45.7 Billion by 2032, growing at 14.7% CAGR

Date : Sep 30, 2024

Transcatheter Devices Market Analysis:

The global transcatheter devices market holds interesting prospects for understanding the changes that are taking place in the healthcare industry. As the medical world shifts towards less invasive procedures, transcatheter devices have received much attention because of their ability to change treatment modalities. These devices are used in various diseases and disorders such as cardiovascular diseases and structural heart diseases, and enable the doctors to perform specific operations without having to conduct an open surgery.

Some of the reasons for the market growth include; the rising population of the elderly, growing incidences of chronic diseases, and enhanced technology in the health sector. As doctors and patients look for therapies with less time to heal and fewer complications, transcatheter devices have become an attractive proposition. Nonetheless, there are barriers to market growth such as regulatory concerns, reimbursement problems, and the need for professional training. However, constant development in device technology, device design, and collaborations with health care providers and manufacturers are anticipated to define the future of the transcatheter devices market.

Key Points and Statistics on the Transcatheter Devices Market:

·       The transcatheter devices market is expected to expand to USD 45.7 billion by 2032, with a CAGR of 14.7% from 2024 to 2032

·       In 2023, the market is estimated to be worth USD 13.4 billion and divided into type, application, and region segments

·       North America is predicted to dominate the transcatheter devices market by 2032

·       Asia-Pacific is expected to develop at the quickest rate from 2023 to 2032

·       Based on type, the transcatheter replacement devices is the leading segment in transcatheter devices market

Request for a sample of this premium research report @ https://www.amecoresearch.com/sample/277064

Transcatheter Devices Market Dynamics

Increasing Prevalence of Cardiovascular Diseases Globally Fuels the Transcatheter Devices Market Growth

The rise in the number of CVD cases across the world is one of the key factors contributing to the expansion of the transcatheter devices market. The diseases like aortic stenosis, mitral regurgitation, and coronary artery disease are on the rise especially among the aging population. Many of these diseases need surgical procedures to fix or replace valves, correct blood flow, or correct congenital heart disease. Transcatheter devices are becoming increasingly popular because they are as effective as open-heart surgeries, and are less invasive and have fewer complications than open-heart surgeries. Therefore, procedures such as Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral Valve Repair (TMVR) remain high, driving the growth of the market.

Also, the global increase in risk factors including hypertension, obesity, diabetes, and sedentary lifestyles has also increased the occurrence of cardiovascular diseases, hence a larger patient base for treatment. This has made the health care providers and systems to consider more complex transcatheter solutions in order to address the increasing need for cardiac services. The steady development of the devices and the growing knowledge of the patients and the physicians regarding the effectiveness of the transcatheter devices shall ensure the market’s steady growth in the future years..

Development of Innovative Transcatheter Devices for Diverse Applications Creates Surplus Transcatheter Devices Market Opportunities

The emergence of novel transcatheter devices for various medical applications is opening up great potential in the transcatheter devices market. Originally developed for cardiovascular procedures, the development of new devices and applications has led to the use of interventional devices in oncology, neurology and urology. For example, transcatheter embolization devices are now being applied to cancer therapy through the occlusion of blood vessels to tumors, and neurology application is in treatment of aneurysms. These innovations provide new less invasive options in many fields of medicine and expand the market beyond its cardiovascular roots.

In addition, constant innovation has seen the development of new generation devices that are safer, more accurate and easier to use. Manufacturers are working to increase the adaptability of these devices to increase the success rate of using these devices in various procedures. They create new opportunities in new markets as the need for new, minimally invasive technologies increases because of the increasing healthcare consciousness and developing infrastructure in these regions. With the increasing number of possible transcatheter applications, the market has the potential to expand in numerous other fields of medicine.

Transcatheter Devices Market Segmentation:

Transcatheter Devices Market Based on Type

·       Transcatheter Embolization and Occlusion Devices

o   Coil

o   Non Coil

·       Transcatheter Replacement Devices

o   Transcatheter Aortic Valve Replacement Devices

o   Transcatheter Pulmonary Valve Replacement

o   Transcatheter Mitral Valve Replacement

·       Transcatheter Repair Devices

o   Transcatheter Mitral Valve Repair

o   Transcatheter Tricuspid Valve Repair

Transcatheter Devices Market Based on Application

·       Cardiovascular

·       Oncology

·       Neurology

·       Urology

·       Others

Transcatheter Devices Market Based on Region

·       North America

·       Asia-Pacific

·       Europe

·       Latin America

·       The Middle East & Africa

Transcatheter Devices Market Regional Overview:

Concerning transcatheter devices market, North America is considered to have the highest market share in the industry and is expected to continue with the same trend in the forecast period. The rise in this region is due to an ageing population at risk of chronic illness, and the higher incidence of cardiovascular and neurological ailments. One research estimated that 40 million people in the United States were over 65 years in 2011 and this is expected to reach 89 million by 2050. Europe is the second largest market for transcatheter devices after North America.

On the other hand, the Asia-Pacific region is growing at an exponential rate and is thus the most promising area of the market. This growth is due to the increase in the number of people living longer, advancement in healthcare facilities, and the shift towards less invasive surgical procedures. In addition, the increased knowledge of modern medical treatments and increased health care expenditures contribute to the growth of the market in the area.

Transcatheter Devices Market Companies:

Prominent players in the transcatheter devices industry include CryoLife, Inc., Abbott, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic plc, enaValve Technology, Inc., Meril Life Sciences Pvt. Ltd., Symetis SA, Neovasc Inc., Terumo Corporation, Venus Medtech (Hangzhou) Inc., and W.L. Gore & Associates.

To receive personalized service, please share your research needs here@ https://www.amecoresearch.com/enquiry-before-buy/277064

Buy this premium research report - https://www.amecoresearch.com/buy/277064

Contact Us:

Mr. Richard

Ameco Research

India: +91 8983225533

E-mail: sales@amecoresearch.com